142 related articles for article (PubMed ID: 1552652)
1. Effect of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in a patient with spinal cord injury.
Muneta S; Iwata T; Hiwada K; Murakami E; Sato Y; Imamura Y
Jpn Circ J; 1992 Mar; 56(3):243-7. PubMed ID: 1552652
[TBL] [Abstract][Full Text] [Related]
2. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
[TBL] [Abstract][Full Text] [Related]
3. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.
Suzuki T; Higa S; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
Neurology; 1981 Oct; 31(10):1323-6. PubMed ID: 6287350
[TBL] [Abstract][Full Text] [Related]
4. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
[TBL] [Abstract][Full Text] [Related]
5. Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa.
Canosa-Hermida E; Mondelo-García C; Ferreiro-Velasco ME; Salvador-de la Barrera S; Montoto-Marqués A; Rodríguez-Sotillo A; Vizoso-Hermida JR
J Spinal Cord Med; 2018 Jan; 41(1):115-118. PubMed ID: 28114866
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury.
Wecht JM; Rosado-Rivera D; Weir JP; Ivan A; Yen C; Bauman WA
Arch Phys Med Rehabil; 2013 Oct; 94(10):2006-12. PubMed ID: 23602882
[TBL] [Abstract][Full Text] [Related]
7. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Birkmayer W; Birkmayer G; Lechner H; Riederer P
J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
[TBL] [Abstract][Full Text] [Related]
8. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
Carvalho MJ; van den Meiracker AH; Boomsma F; Man in 't Veld AJ; Freitas J; Costa O; de Freitas AF
J Auton Nerv Syst; 1997 Jan; 62(1-2):63-71. PubMed ID: 9021651
[TBL] [Abstract][Full Text] [Related]
9. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
[TBL] [Abstract][Full Text] [Related]
10. [A case of diabetic orthostatic hypotension effectively managed with L-dops (L-threo-3,4-dihydroxyphenylserine)].
Yoshikawa H; Kawai K; Inoue S; Murayama Y; Kuzuya N; Fujita T; Koide Y; Yamashita K; Yoshizawa K; Mizusawa H
Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1695-700. PubMed ID: 3151075
[No Abstract] [Full Text] [Related]
11. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Kaufmann H
Clin Auton Res; 2008 Mar; 18 Suppl 1():19-24. PubMed ID: 18368303
[TBL] [Abstract][Full Text] [Related]
12. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
[TBL] [Abstract][Full Text] [Related]
14. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
Lamotte G; Holmes C; Sullivan P; Goldstein DS
Clin Auton Res; 2019 Feb; 29(1):113-117. PubMed ID: 30229336
[TBL] [Abstract][Full Text] [Related]
15. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance.
Tanaka H; Yamaguchi H; Mino M
Clin Auton Res; 1996 Aug; 6(4):189-93. PubMed ID: 8902314
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
Akizawa T; Koshikawa S; Iida N; Marumo F; Akiba T; Kawaguchi Y; Imada A; Yamazaki C; Suzuki M; Tubakihara Y
Nephron; 2002 Apr; 90(4):384-90. PubMed ID: 11961396
[TBL] [Abstract][Full Text] [Related]
17. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
Hoeldtke RD; Cilmi KM; Mattis-Graves K
Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
[TBL] [Abstract][Full Text] [Related]
18. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
Iida N; Koshikawa S; Akizawa T; Tsubakihara Y; Marumo F; Akiba T; Kawaguchi Y; Imada A; Yamazaki C; Suzuki M
Am J Nephrol; 2002; 22(4):338-46. PubMed ID: 12169865
[TBL] [Abstract][Full Text] [Related]
19. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).
Hauser RA; Hewitt LA; Isaacson S
J Parkinsons Dis; 2014; 4(1):57-65. PubMed ID: 24326693
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
